Health CanadaGeneral Alert
Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity
Published: May 21, 2019Recall ID: 59146Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity
Recalling Firm: Marketed health products
Product Description & Identification
Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity
Additional Source Details
| Field | Value |
|---|---|
| N I D | 59146 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/important-safety-information-actemrar-tocilizumab-risk-hepatotoxicity |
| Title | Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity |
| Archived | 0 |
| Category | Drugs - Biologic or vaccine |
| Last updated | 2019-05-21 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity Check if your household is affected: https://therecallfile.com/recalls/important-safety-information-on-actemra-tocilizumab-risk-of-hepatotoxi/CANADA-59146
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordImportant Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity